May 2026 | Neuroscience News Roundup

May 14, 2026

This month's pediatric neuroscience developments highlight major advances in early autism detection, pediatric attention research, neurodevelopmental genetics, infant brain maturation, and systems-based pediatric neurology care. These findings reinforce the growing role of precision medicine and early intervention in child neurology.



Early Autism Detection Through Wearable Technology

Researchers at UCLA Health are developing wearable sensor technology capable of detecting subtle motor abnormalities in infants at high risk for autism spectrum disorder (ASD). The study uses wrist- and ankle-based sensors combined with machine learning algorithms to identify movement variability before traditional behavioral symptoms emerge.


Why This Matters

Motor differences often precede language and social communication changes in ASD. Earlier identification could allow intervention during critical neurodevelopmental windows when neuroplasticity is greatest.


Clinical Implications for Pediatric Neuroscience Nurses

  • Increased emphasis on developmental surveillance during infancy
  • Potential integration of digital biomarkers into pediatric neurology clinics
  • Expanded family education regarding early motor signs of ASD


References

  • Nature Reviews Neurology
    Lord, C., et al. (2020).
    Autism spectrum disorder. Nature Reviews Disease Primers, 6, 5.
  • JAMA Pediatrics
    Landa, R. J., et al. (2013).
    Developmental trajectories in infants with autism spectrum disorders. JAMA Pediatrics, 167(7), 629–638. 



Brain Signals May Predict Attention Lapses in Children

A newly identified neural “attention signature” may predict lapses in attention before they occur in children. Investigators demonstrated that real-time recognition of this brain signal could restore focus using targeted interventions.


Why This Matters

This research may have implications for:

  • ADHD diagnostics
  • Pediatric cognitive rehabilitation
  • Neurofeedback interventions
  • Classroom attention monitoring technologies


Clinical Implications

  • Future development of individualized neurocognitive therapies
  • Potential non-pharmacologic interventions for attention disorders
  • Improved objective biomarkers for pediatric attentional dysfunction


References

  • Neuron
    Posner, M. I., & Petersen, S. E. (1990).
    The attention system of the human brain. Neuron, 13(1), 25–42.
  • Biological Psychiatry
    Castellanos, F. X., & Proal, E. (2012).
    Large-scale brain systems in ADHD. Biological Psychiatry, 72(3), 192–197. 



Infant Sleep Emerging as a Neurodevelopmental Biomarker

A new review in Pediatric Research emphasizes the critical relationship between infant sleep architecture and early brain development. Researchers highlight sleep spindle maturation as a potential biomarker for neurodevelopmental outcomes.


Why This Matters

Sleep quality and organization during infancy may influence:

  • Cognitive development
  • Memory consolidation
  • Synaptic maturation
  • Long-term neurodevelopmental outcomes


Clinical Implications

  • Reinforces importance of sleep assessment in developmental evaluations
  • Supports parent education on sleep hygiene
  • May influence NICU and infant follow-up practices


References

  • Sleep Medicine Reviews
    Jan, J. E., et al. (2010).
    Sleep hygiene for children with neurodevelopmental disabilities. Sleep Medicine Reviews, 14(6), 389–396.
  • Nature Reviews Neuroscience
    Frank, M. G. (2011).
    Sleep and synaptic plasticity in the developing brain. Nature Reviews Neuroscience, 12, 477–488. 



New Genetic Insights Into Neurodevelopmental Disorders

Researchers from Baylor College of Medicine and Texas Children’s Hospital identified a gene-disease association involving ASTN1, a gene critical for neuronal migration and cortical development.


Why This Matters

The findings help explain previously undiagnosed neurodevelopmental syndromes and reinforce the role of genetic sequencing in pediatric neurology.


Clinical Implications

  • Expanding role of neurogenetics in diagnostic evaluation
  • Increased importance of interdisciplinary genetic counseling
  • Potential future precision therapies targeting neuronal migration pathways


References

  • Lancet Neurology
    Guerrini, R., & Dobyns, W. B. (2014).
    Malformations of cortical development. Lancet Neurology, 13(7), 710–726.
  • Neuron
    Valiente, M., & Marín, O. (2010).
    Neuronal migration mechanisms. Neuron, 66(4), 573–587. 



Early Screen Exposure & Adolescent Brain Outcomes

Longitudinal data continue to show associations between excessive screen exposure before age two and later anxiety symptoms, altered cognitive flexibility, and changes in brain network maturation.


Why This Matters

This reinforces concerns surrounding early digital exposure during sensitive neurodevelopmental periods.


Clinical Implications

  • Strengthens anticipatory guidance recommendations for families
  • Encourages developmental counseling around media exposure
  • Supports integration of environmental history into pediatric assessments

 

References

  • Pediatrics
    Madigan, S., et al. (2019).
    Association between screen time and children’s performance on developmental screening tests. Pediatrics, 143(4).
  • JAMA Pediatrics
    Hutton, J. S., et al. (2020).
    Associations between screen-based media use and brain white matter integrity. JAMA Pediatrics, 174(1), e193869. 



Stoke Therapeutics Announces First Quarter 2026 Financial Results and Provides Business Updates

Stoke Therapeutics, Inc. (Nasdaq: STOK) is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine and has a lead investigational medicine, zorevunersen, in development with Biogen (Nasdaq: BIIB) as a first-in-class potential disease-modifying treatment for Dravet syndrome. The Company today reported financial results for the first quarter ended March 31, 2026, and announced new 4-year longitudinal data from the ongoing Phase 1/2a open-label extension (OLE) studies that provide additional support for zorevunersen as a potential disease-modifying treatment for Dravet syndrome. Statistically significant improvements were demonstrated in cognition and behavior at 1, 2, 3 and 4 years of treatment compared to OLE baseline. Reductions in major motor seizure frequency were observed through 4 years of treatment in patients taking standard anti-seizure medicines (ASMs). Zorevunersen continues to be generally well tolerated, with some patients treated for more than 5 years in the Phase 1/2a and ongoing OLE studies.


The Company also announced an update on progress of the global Phase 3 EMPEROR study. Enrollment of approximately 150 patients in the U.S., UK and Japan is expected to complete in June 2026 to support a data readout in mid-2027. These data are anticipated to complete the rolling New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) planned to initiate in the first quarter of 2027.


Read the full press release here: https://investor.stoketherapeutics.com/news-releases/news-release-details/stoke-therapeutics-announces-first-quarter-2026-financial

April 24, 2026
The neuroscience landscape continues to evolve at an accelerated pace, with innovations in neurotechnology, neurodegenerative disease, and neurodevelopment shaping the future of patient care. This week's highlights emphasize the growing role of precision medicine, brain–body connections, and translational science in clinical practice. Brain Signals & Neurophysiology New research from Northwestern Medicine provides deeper insight into how high-gamma brain activity—a key signal used in EEG and intracranial monitoring—is generated at the cellular level. These findings may refine how we interpret neural activity in epilepsy, cognition, and BCI applications. High-frequency activity has long been associated with cortical processing, but this work suggests more precise cellular drivers , potentially improving diagnostic accuracy in neurophysiology. Northwestern Medicine. (2026). High gamma activity and neural signaling. Neuro-oncology: Brain–Tumor Interactions A new study shows that certain non-neuronal brain cells actively promote glioblastoma growth through signaling pathways previously thought to be supportive only of normal brain function. Blocking these signals significantly reduced tumor progression in models. This aligns with growing literature on the tumor microenvironment , emphasizing neuron–glia–tumor interactions as therapeutic targets. Venkataramani, V., et al. (2026). Neuron–glioma interactions in tumor progression.  Neuroplasticity & Regeneration Research published in Current Biology highlights how “tunneling neurons” in songbirds enable ongoing neurogenesis in adulthood. This mechanism may explain why humans have limited regenerative capacity—and how it might be therapeutically induced. These findings contribute to regenerative neuroscience, suggesting a trade-off between memory stability and neuronal renewal . Scott, B., et al. (2026). Neurogenesis via tunneling neurons. Current Biology. Brain Development & Big Data Neuroscience A major multi-omics database integrating data from 188 studies has mapped human neocortical development at unprecedented resolution , improving understanding of how the brain develops layer-by-layer and cell-by-cell. Large-scale datasets are accelerating precision neurodevelopmental modeling , with implications for congenital disorders and pediatric neurology. University of Maryland School of Medicine. (2026). Neocortical development database. Neurodegeneration: Expanding Disease Models Emerging evidence suggests that some motor symptoms in Alzheimer’s disease may originate outside the brain , challenging traditional CNS-only models of neurodegeneration. In parallel, new work indicates that gut microbiota may contribute to ALS and frontotemporal dementia through immune-mediated pathways. UCF Research. (2026). Peripheral origins of Alzheimer’s motor symptoms. ScienceDaily. (2026). Gut microbiome in ALS/FTD. Fundamental Neuroscience: Epigenomics & Brain Identity New data in Nature Neuroscience reveal epigenomic signatures in adult glial cells that resemble developmental states, suggesting roles in regeneration and disease processes. Dere, E. (2026). Mental time travel and cognition. Psychological Review. Kabbe, et al. (2026). Epigenomic profiling of CNS cells. Nature Neuroscience. Autism & Neurodevelopment Advances A new research initiative is exploring targeted autism therapies, focusing on underlying biology rather than symptom management. This reflects a broader shift toward mechanism-based treatments in neurodevelopmental disorders. MUSC researchers hope to develop autism treatment | MUSC
April 16, 2026
Overview The neuroscience landscape continues to evolve at an accelerated pace, with innovations in neurotechnology, neurodegenerative disease, and neurodevelopment shaping the future of patient care. This month’s highlights emphasize the growing role of precision medicine, brain–body connections, and translational science in clinical practice. Neurotechnology & Functional Recovery Recent advances in brain–computer interface (BCI) technology demonstrate meaningful progress toward restoring both motor and sensory function in individuals with paralysis. These systems are moving beyond assistive communication toward functional neurologic recovery. In addition, emerging intranasal therapies designed to bypass the blood–brain barrier show promise in reducing neuroinflammation and improving mitochondrial function—potentially opening new treatment pathways for brain injury and neurodegenerative disease. Clinical Relevance Increasing need for nurse familiarity with neurodevices and emerging therapies Expanded role in patient/caregiver education and longitudinal care coordination Growing intersection between acute care and neurorehabilitation Nature Neuroscience Willett, F. R., et al. (2023). High-performance brain-to-text communication via handwriting decoding. Nature , 593, 249–254. The New England Journal of Medicine Moses, D. A., et al. (2021). Neuroprosthesis for decoding speech in a paralyzed person with anarthria . N Engl J Med , 385, 217–227. Nature Medicine Bouton, C. E., et al. (2016). Restoring cortical control of functional movement in a paralyzed individual. Nat Med , 22, 153–156. Neurodegenerative Disease & Precision Medicine New findings highlight the importance of individualized approaches to neurologic care: Alzheimer’s disease: Sex-based differences may delay diagnosis in women despite underlying pathology Parkinson’s disease: The gut microbiome may reduce the effectiveness of levodopa through drug metabolism Dementia prevention: High-quality, whole-food plant-based diets are associated with lower cognitive decline risk Clinical Relevance Consider sex-specific presentation in cognitive assessments Recognize emerging medication–microbiome interactions Reinforce lifestyle counseling as part of neurologic care Lancet Neurology Livingston, G., et al. (2020). Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet Neurol , 19(5), 413–446. JAMA Neurology Ferretti, M. T., et al. (2018). Sex differences in Alzheimer disease — the gateway to precision medicine. JAMA Neurol , 75(11), 1361–1362. Cell Maini Rekdal, V., et al. (2019). Discovery and inhibition of an interspecies gut bacterial pathway for Levodopa metabolism. Cell , 177(6), 1580–1591. Brain Function & Translational Science Advances in fundamental neuroscience are uncovering mechanisms with direct clinical implications: Specialized intracellular transport systems in neurons may contribute to neurodegenerative disease processes Overlapping neural pathways for visual perception and imagination provide insight into cognition, hallucinations, and rehabilitation strategies Clinical Relevance Supports neuroplasticity-based rehabilitation approaches Enhances understanding of cognitive and perceptual symptoms Neuron Maday, S., Twelvetrees, A. E., Moughamian, A. J., & Holzbaur, E. L. (2014). Axonal transport: cargo-specific mechanisms of motility and regulation. Neuron , 84(2), 292–309. Nature Reviews Neuroscience Pearson, J. (2019). The human imagination: the cognitive neuroscience of visual mental imagery. Nat Rev Neurosci , 20, 624–634. Neurodevelopment & Early Brain Health Emerging research suggests that critical developmental pathways—such as neural crest cell differentiation—occur earlier than previously recognized. Additionally, the gut microbiome is increasingly linked to neurodevelopmental outcomes, including autism and ADHD. Clinical Relevance Reinforces importance of early developmental screening Supports family education on environmental and biological influences Highlights future directions in prevention and early intervention Nature Reviews Neuroscience Molnár, Z., et al. (2019). New insights into the development of the human cerebral cortex. Nat Rev Neurosci , 20, 499–512. Cell Sharon, G., et al. (2019). Human gut microbiota from autism spectrum disorder promote behavioral symptoms in mice. Cell , 177(6), 1600–1618. Lifestyle, Brain Health & Environment The role of lifestyle and environment in neurologic health continues to expand: Meditation is associated with measurable neuroplastic and immunologic changes The brain encodes prior physical activity (“exercise memory”), influencing endurance “Neuroarchitecture” explores how built environments impact stress, cognition, and neurologic health Clinical Relevance Integrate holistic care strategies into practice Encourage physical activity and stress management Consider environmental factors in recovery and long-term brain health Nature Reviews Neuroscience Tang, Y. Y., Hölzel, B. K., & Posner, M. I. (2015). The neuroscience of mindfulness meditation. Nat Rev Neurosci , 16, 213–225. Journal of Physiology Noakes, T. D. (2012). Fatigue is a brain-derived emotion that regulates exercise behavior. J Physiol , 590(15), 3469–3470. Environmental Health Perspectives Berman, M. G., Jonides, J., & Kaplan, S. (2008). The cognitive benefits of interacting with nature. Environ Health Perspect , 117(7), 1045–1050. The Lancet Planetary Health Nieuwenhuijsen, M. J. (2021). Urban and transport planning pathways to carbon neutral, liveable and healthy cities. Lancet Planet Health , 5(8), e533–e539. Key Takeaways for Neuroscience Nurses Neurotechnology is shifting toward restorative care models Precision medicine is becoming central to neurologic diagnosis and treatment The microbiome is an emerging factor in neurologic disease management Early neurodevelopmental insights emphasize timely intervention Lifestyle and environment are critical components of brain health
April 16, 2026
Workforce Development & Pipeline Expansion Efforts to strengthen the child neurology workforce are gaining momentum, with increased focus on early exposure and training pathways for future clinicians. New initiatives emphasize integrating neurology earlier into medical and advanced practice education to address ongoing workforce shortages. Building the Child Neurology Workforce Earlier in Training | NeurologyLive - Clinical Neurology News and Neurology Expert Insights Why it matters for ACNN: This creates opportunities for nurse practitioners and nurses to play a larger role in education, mentorship, and interdisciplinary training models. Innovations Shaping Neurology Practice Experts highlight artificial intelligence, precision medicine, and emerging disease-modifying therapies as key drivers transforming neurologic care in 2026. These innovations are expected to enhance diagnostics, personalize treatment, and improve long-term outcomes. Look Ahead in Neurology: What are Clinicians Excited About for 2026? | NeurologyLive - Clinical Neurology News and Neurology Expert Insights Clinical impact: AI-supported diagnostics and monitoring Expansion of targeted therapies Greater emphasis on individualized care plans Advocacy & Policy Progress Recent advocacy efforts have led to early legislative and policy advancements supporting child neurology priorities, including workforce support and improved access to care. Advocacy Update: Early Wins for Child Neurology in Congress - Child Neurology Society Implications: Increased national visibility of pediatric neurologic conditions Opportunities for nursing leadership in advocacy initiatives
Show More